Neutrophils play an important role in antimicrobial defense as the first line of innate immune system. Recently, the release of neutrophil extracellular traps (NETs) has been identified as a killing mechanism of neutrophils against invading microbes. Mycoplasma pneumoniae, a causative agent of respiratory infection, has been shown to be resistant to in vitro killing by neutrophils, suggesting that the bacterium might circumvent bactericidal activity of NETs. In this study, we investigated whether M. pneumoniae possesses resistance mechanisms against the NETsmediated killing of neutrophils and found that the bacterium degrades the NETs induced upon M. pneumoniae infection. The NETs-degrading ability of M. pneumoniae required the production of a secreted nuclease, Mpn491, capable of using Mg 2+ as a cofactor for its hydrolytic activity.
| INTRODUCTION
Mycoplasma pneumoniae is a human pathogen that causes atypical pneumonia and other respiratory disorders, including bronchitis and pharyngitis (Waites & Talkington, 2004; Atkinson, Balish, & Waites, 2008; Lamoth & Greub, 2010) . Upon M. pneumoniae infection, host cells, such as respiratory epithelial cells and pulmonary macrophages, produce a wide variety of proinflammatory cytokines that coordinately activate the host defense (Saraya et al., 2014) . Among the cytokines, IL-8 is a key mediator in the recruitment and activation of neutrophils.
It has been shown that patients with M. pneumoniae pneumonia exhibit increased levels of IL-8 in their bronchoalveolar lavage fluids (BALFs) as well as an increase of alveolar infiltration with neutrophils (Narita et al., 2001; Saraya et al., 2014; Chen et al., 2016) .
Neutrophils act as the first line of innate immune defense against pathogenic microbes. They are recruited to the site of infection, followed by containment and clearance of the microbes by phagocytosis. Besides phagocytic activity, release of neutrophil extracellular traps (NETs) has been identified as an alternative mechanism of killing invading microbes (Brinkmann et al., 2004; Papayannopoulos & Zychlinsky, 2009; Kaplan & Radic, 2012) . NETs are generated by a process termed NETosis, which is induced by stimulation, including phorbol 12-myristate 13-acetate (PMA), IL-8, and microbial infections. The signaling mechanisms that trigger NETosis are poorly understood. However, the process has been shown to require generation of reactive oxygen species by nicotinamide adenine dinucleotide phosphate-oxidase (Fuchs et al., 2007) , calcium ion flux (Neeli, Khan, & Radic, 2008) and peptidylarginine deiminase 4-dependent histone citrullination (Li et al., 2010b) . NETs are web-like structures comprised of chromatin associated with antimicrobial granule proteins, which can entrap and efficiently kill microbes, such as Escherichia coli (Grinberg, Elazar, Rosenshine, & Shpigel, 2008) , Listeria monocytogenes (Ramos-Kichik et al., 2009) , Salmonella typhimurium, Shigella flexneri (Brinkmann et al., 2004) , and Yersinia enterocolitica (Casutt-Meyer et al., 2010) , with high local concentrations of antimicrobial components. On the other hand, some pathogens, such as Streptococcus pneumoniae (Beiter et al., 2006) , Haemophilus influenzae (Juneau, Pang, Weimer, Armbruster, & Swords, 2011) , Pseudomonas aeruginosa (Young et al., 2011) , Mycobacterium tuberculosis (Ramos- Kichik et al., 2009) , and Vibrio cholerae (Seper et al., 2013) , have evolved to circumvent the bactericidal activity of NETs. They are known to have a variety of strategies against the NETs killing; alteration of cell surface (e.g., surface charge) to reduce entrapping and killing by NETs, production of extracellular nuclease that degrades chromatin fibers of NETs, and inhibition of some steps in the process of NETosis (Lu, Kobayashi, Quinn, & Deleo, 2012; Hahn, Giaglis, Chowdhury, Hösli, & Hasler, 2013; Halverson, Wilton, Poon, Petri, & Lewenza, 2015) . These immune evasion strategies facilitate survival of the bacteria and establishment of persistent infection.
It is unclear whether the NETs are formed in response to M. pneumoniae infection and participate in the killing and elimination of this bacterium. However, previous reports showed that coincubation of mycoplasmas with neutrophils does not affect the viability of the bacteria (Zucker-Franklin, Davidson, & Thomas, 1966; Howard & Taylor, 1983) , and depletion of neutrophils does not alter clearance of M. pneumoniae from respiratory tract in the mouse infection model (Lai et al., 2010) , either. These findings imply that M. pneumoniae has an ability to evade killing mechanisms of neutrophils. M. pneumoniae has also been shown to escape phagocytic killing of neutrophils (Marshall, Miles, & Richards, 1995) . Hence, we hypothesized that the bacterium can resist bactericidal activity of NETs.
In the present study, we investigated whether M. pneumoniae possesses a resistance mechanism to the NETs-mediated killing.
We observed that neutrophils release NETs after exposure to M. pneumoniae, and subsequently, the released NETs are degraded by M. pneumoniae. Furthermore, we found that M. pneumoniae produces a secreted nuclease, Mpn491. The mutant strain deficient for Mpn491 impaired the NETs-degrading ability and exhibits increased susceptibility to neutrophil killing. Collectively, the results suggest that the Mpn491 with nuclease activity plays a pivotal role in the evasion of bactericidal activity of NETs in M. pneumoniae.
| RESULTS

| M. pneumoniae evades NETs-mediated killing
In order to determine whether M. pneumoniae exhibits a resistance to NETs-mediated killing by neutrophils, M. pneumoniae were incubated with polymorphonuclear leukocytes (PMNs) for 6 hr in the presence or absence of DNase I that degrades and inactivates NETs, and then the number of survived bacteria was determined.
Consistent with the previous reports (Zucker-Franklin et al., 1966; Howard & Taylor, 1983; Lai et al., 2010) , co-incubation with PMNs failed to show significant effect on the viability of the bacterium (Figure 1a) . Moreover, there was no significant difference in the number of survived bacteria regardless of the presence of DNase I.
Treatment of DNase I alone did not affect the viability of M. pneumoniae (Figure 1b) . The results suggested that M. pneumoniae is resistant to bactericidal activity of neutrophils and may possess some strategies to circumvent NETs-mediated killing.
| M. pneumoniae degrades NETs
To clarify the molecular basis for evasion of NETs-mediated killing by M. pneumoniae, we first examined whether NETs are formed by PMNs upon M. pneumoniae infection. Heat-killed M. pneumoniae as well as PMA stimulation induced the formation of a large number of NETs by PMNs (Figure 2a,b) . In contrast, very little number of NETs was observed after infection with live M. pneumoniae, suggesting that M. pneumoniae interferes the process involving the release of NETs by PMNs or possesses some factor(s) capable of degrading NETs.
Citrullination of histones has been shown to be a process required for NETosis. In order to elucidate whether M. pneumoniae infection interferes NETosis, we compared the citrullination of histone H3 in PMNs incubated with live and heat-killed M. pneumoniae. Figure 2c and d shows that citrullinated histone H3 was markedly increased by infection of M. pneumoniae, and there was no significant difference in intensities of the bands between PMNs incubated with live and heatkilled M. pneumoniae. To further determine whether NETs were released after the histone citrullination, translocation of histone H3 that is a component of NETs into the extracellular space was analyzed by Western blotting. The amount of histone H3 detected in culture supernatants from PMNs infected with M. pneumoniae was comparable to that from the cells stimulated with heat-killed M. pneumoniae (Figure 2e ,f). These findings raised a possibility that M. pneumoniae induces the formation of NETs followed by the degradation of themselves. Then, we determined whether M. pneumoniae possesses the ability to degrade NETs. As shown in Figure 2g and h, PMAinduced NETs were markedly decreased by the incubation with live M. pneumoniae, whereas the incubation with heat-killed M. pneumoniae failed to decrease the NETs. Moreover, the observation of timedependent changes in NETs integrity revealed that the NETs were gradually degraded by the incubation with M. pneumoniae (Figure 2i ), suggesting that neutrophils release NETs upon M. pneumoniae infection, and subsequently, the released NETs are degraded by M. pneumoniae.
| M. pneumoniae produces a secreted nuclease
The data presented in Figure 2 strongly suggested that M. pneumoniae produces some factor(s) capable of degrading NETs. NETs have been shown to be degraded by extracellular nucleases released from some bacteria; therefore, we examined whether M. pneumoniae produces an extracellular nuclease. Colorimetric analysis of DNase activity by using DNA-methyl green revealed that a strong activity of DNase was detected around the colonies of M. pneumoniae (Figure 3a) , FIGURE 1 M. pneumoniae evades NETs-mediated killing. (a) PMNs were infected with M. pneumoniae at a multiplicity of infection (MOI) of 2 and cultured for 6 hr in the presence or absence of 100 U/ml DNase I. The infected cell suspension was inoculated on PPLO agar plates to enumerate the bacterial number. Percent survival was determined relative to the number of input bacteria. (b) M. pneumoniae was cultured in OptiMEM with or without DNase I for 6 hr. The number of M. pneumoniae was determined by plating bacterial suspensions on PPLO agar plates followed by counting of colonies after cultivation. Percent bacterial growth was determined relative to the number of bacteria in OptiMEM without DNase I. All data represent the means of duplicate assays and standard deviations. Similar results were obtained in three independent experiments using PMNs isolated from independent donors. NS = not significant; NT = no treat indicating that M. pneumoniae produces extracellular nuclease. To determine whether the nuclease is produced as membrane-bound or secretory form, we examined the DNase activity of the cell lysate and culture supernatant of M. pneumoniae. The culture supernatant exhibited a strong DNase activity (Figure 3b Figure S1 ). However, the growth rate of the mutant strain was significantly lower than that of the wild-type strain ( Figure 4e ).
According to the Genpept database, the gene product, Mpn491, contains the endonuclease-exonuclease-phosphatase (EEP) domain that is responsible for the nuclease activity ( Figure 4f ). The predicted , as a cofactor for their enzymatic activity (Campbell & Jackson, 1980; Steitz & Steitz, 1993; Dominguez & Ward, 2009) 
| Mpn491 contributes to the degradation of NETs in mouse model of infection
Here, we showed that Mpn491 is crucial for the resistance of and found that mpn491 mRNA was detected in BALFs from mice infected with M. pneumoniae. The expression levels during in vivo infection were lower than that during early to late log phases but higher than that during decline phase of in vitro culture (Figure 7c ).
Here, it is of note that the bacterial growth of M. pneumoniae was reported to be limited in a mouse (Lai et al., 2010) , suggesting that M. pneumoniae expresses only a low amount of mpn491 mRNA in an infected mouse as with stationary to decline phases of in vitro culture.
To further examine whether Mpn491 plays a role in a sustained infection of M. pneumoniae in the murine lung by the degradation of NETs, we compared the bacterial viability between wild-type and Mpn491-deficient mutant strains of M. pneumoniae by the determination of relative amount of 16S rRNA in the BALFs (Figure 7d ). The relative amount of 16S rRNA in BALFs obtained from mice infected with the mutant strain of M. pneumoniae was significantly lower than that with the wild-type strain at 24 hr after infection, indicating that interfere the killing activity of neutrophils, contributing to the establishment of infection. M. pneumoniae is known to exhibit resistance to neutrophil killing; however, the factor responsible for the resistance has not yet been revealed. In this study, we found that Mpn491, a secreted nuclease released from M. pneumoniae, is crucial for the resistance of the bacterium against the assault of NETs released from neutrophils.
The resistance mechanisms against NETs-mediated killing by neutrophils could be divided into three types; alteration of cell surface to reduce the killing by NETs, degradation of NETs by an extracellular nuclease, and inhibition of the process of NETosis. As shown in Figure 2a and b, the NETs formation mostly could not be observed in PMNs infected with M. pneumoniae, whereas the infection of the PMNs with M. pneumoniae induced both NETosis and release of NETs (Figure 2c,d,e,f) . Then, we have assumed that the resistance of the bacterium against NETs-mediated killing is due to the degradation of NETs by an extracellular nuclease produced by M. pneumoniae. We actually found the Mpn491 as a responsible factor of M. pneumoniae to evade NETs-mediated killing.
On the other hand, in this study, we omitted the analysis to determine whether M. pneumoniae possesses intrinsic resistance to the antimicrobial components of NETs because previous reports have shown that M. pneumoniae shows susceptibility to antimicrobial factors of neutrophils, including elastase (Gally et al., 2011) (a) and (b). PMA-induced NETs were incubated with wild-type and mutant M. pneumoniae for 3 hr. After fixation of cells, NETs were visualized by immunofluorescent staining with an anti-myeloperoxidase antibody (red) and Sytox green (green) (a) and the percentage of NETs-releasing PMNs was determined (b). Scale bar represents 20 μm. (c) PMNs were infected with wild-type and mutant M. pneumoniae at a MOI of 2 and cultured for 6 hr in the presence or absence of 100 U/ml DNase I. The infected cell suspension was inoculated on PPLO agar plates to enumerate the bacterial number. Percent survival was determined relative to the number of input bacteria. (d) M. pneumoniae strains were cultured in OptiMEM with or without 5 μg/ml salmon sperm DNA or 5 μg/ml NMPs for 6 hr. The number of the bacteria was determined by plating the bacterial suspensions on PPLO agar plates followed by counting of colonies after cultivation. Percent growth of M. pneumoniae strains was determined relative to the number of bacteria in OptiMEM without nucleic acids. All data in panel (b), (c), and (d) represent the means of duplicate assays and standard deviations. Similar results were obtained in three independent experiments using PMNs isolated from independent donors. NS = not significant; * = p < 0.05
We found that Mpn491 requires Mg 2+ for its hydrolytic activity, and the activity is decreased by the presence of Zn
2+
. The concentration of Mg 2+ in sputum is around 1 mM (Bowdish, Davidson, & Hancock, 2006) , whereas median concentration of Zn 2+ in sputum is a few hundred nM (Meydani et al., 2007; Gray et al., 2010; Jayaram, Chunilal, Pickering, Ruffin, & Zalewski, 2011) . However, Jayaram et al. (2011) have reported that Zn 2+ levels in sputum ranges from 0 to over 10 μM, suggesting that although the nuclease can most likely work in vivo infection of M. pneumoniae, it could not show its full activity in some patients. These findings raised a possibility that the Zn 2+ concentration in the site of infection could be a critical determinant for the susceptibility to M. pneumoniae infection. It has been reported that Zn 2+ concentrations in sputum are lower in patients with asthma compared with healthy subjects (Jayaram et al., 2011) , suggesting that the patients with asthma might be more susceptible to the infection of M. pneumoniae. Indeed, M. pneumoniae infection is known as a frequent cause of exacerbation of asthmatic symptoms (Hong, 2012) . Furthermore, it has been shown that serum Zn 2+ concentration is associated with decreased incidence of pneumonia, and supplementation of Zn 2+ prevents pneumonia incidence and associated morbidity (Yamey, 1999; Meydani et al., 2007) .
Therefore, M. pneumoniae infection might also be prevented by the supplementation of Zn 2+ .
Mycoplasma nucleases were first reported in 1964 (Razin, Knyszynski, & Lifshitz, 1964) and have been found in numerous species of mycoplasmas to date (Minion, Jarvill-Taylor, Billings, & Tigges, 1993) . Among the mycoplasmas, human mycoplasmas, including M. hominis and M. genitalium, have been shown to exhibit membrane-associated nuclease activities (Minion et al., 1993; Li et al., 2010b) . In M. pneumoniae, a membrane nuclease, Mpn133, has also been identified (Somarajan, Kannan, & Baseman, 2010) , which has been shown to bind and internalize into mammalian cells due to the presence of a unique amino-acid sequence, glutamic acid-lysine-serine-rich region, and subsequently induce apoptosislike cell death. In this study, we failed to observe nuclease activity in the mutant strain deficient for Mpn491 (Figure 4) . The results suggested that hydrolytic activity or the expression level of Mpn133 may be apparently lower than that of Mpn491, and it might be possible that Mpn133 is less important for the resistance of M. pneumoniae to NETs-mediated killing than Mpn491. Meanwhile, another study reported that Mpn491 possesses glutamic acid-lysine-serine region-like amino-acid sequence between residues 
| Animals used in this study
Wild-type female BALB/c mice were purchased from Japan SLC (Shizuoka, Japan) and Kyudo (Saga, Japan). Mice were maintained in specific-pathogen-free conditions and used at 6 to 7 weeks of age.
All of the experimental procedures performed on mice were approved by the Institutional Animal Care and Use Committee of Kurume University School of Medicine.
| PMNs isolation
PMNs were isolated from peripheral blood of an adult human volunteer using Mono-Poly Resolving Medium (DS pharma biomedical, Osaka, Japan), according to manufacturer's instructions. About 3.5 ml of peripheral blood collected in the presence of 15 U/ml heparin sodium (Ajinomoto, Tokyo, Japan) was layered over 3 ml of Mono-Poly
Resolving Medium, and centrifuged at 400 x g for 20 min. 
| Neutrophil killing assay
PMNs in the microcentrifuge tube were infected with M. pneumoniae strains at a multiplicity of infection (MOI) of 2 and incubated for 6 hr in the presence or absence of 100 U/ml DNase I (Worthington, Lakewood, NJ). The infected cell suspension was mixed every hour by inversion of the tube during 6-hr incubation. Subsequently, all samples except the samples having treated DNase I were treated with 100 U/ml DNase I for 30 min to liberate the bacteria trapped by NETs.
To determine the number of survived bacteria, the infected cell suspensions were serially diluted and inoculated on PPLO agar plates followed by counting of colonies after cultivation for 2 weeks. Percent survival was determined relative to the number of input bacteria.
4.5 | Growth of M. pneumoniae M. pneumoniae strains were incubated in PPLO broth, and bacterial cells were collected using a cell scraper every 12 hr. The number of M. pneumoniae was determined by plating serially diluted bacterial suspensions on PPLO agar plates followed by counting of colonies.
Alternatively, M. pneumoniae strains were incubated in OptiMEM with or without 100 U/ml DNase I, 5 μg/ml salmon sperm DNA (Trevigen, Gaithersburg, MD) and 5 μg/ml NMPs (AMP, TMP, and CMP were purchased from Nacalai Tesque, Kyoto, Japan, and CMP was purchased from TCI, Tokyo, Japan) for 6 hr. The number of M. pneumoniae was determined as described above. Percent bacterial growth was determined relative to the number of bacteria incubated in the absence of any reagents.
4.6 | Preparation of culture supernatant and cell lysate of M. pneumoniae M. pneumoniae strains were grown to the late log-phase. One milliliter of the bacterial culture was added to 5 ml of fresh PPLO broth, and cultured for 48 hr. The culture supernatants were collected and filtrated through 0.2 μm filters (Advantec, Tokyo, Japan).
Concomitantly, the bacterial cells were harvested, washed twice with PBS, and centrifuged. The pellets were resuspended in 6 ml of 50 mM Tris-HCl (pH 7.4) and sonicated for 2 min using a Handy Sonic UR-20P (Tomy Seiko, Tokyo, Japan) and centrifuged. The supernatants were collected and used as the cell lysate.
| Immunofluorescence analysis of NETs formation
PMNs seeded in an eight-well chamber slide were infected with live or 4.10 | DNase assay by DNA-methyl green DNase production of M. pneumoniae was determined by colorimetric assays using DNA-methylgreen as a substrate. To examine the presence of nuclease around colonies of M. pneumoniae strains, bacterial cultures were spotted on PPLO agar plate and cultured for 2 weeks.
The culture plate was overlaid with 1% noble agar (Difco) containing 0.5 mg/ml DNA-methylgreen (Sigma). DNase production was defined by an appearance of clear halo around the colony after incubation for 24 hr at 37°C. For liquid assay, bacterial cell lysates and culture supernatants were mixed with equal volumes of 0.1 mg/ml DNAmethylgreen in 50 mM Tris-HCl (pH 7.4) and incubated for 24 hr at 37°C. The absorbance at 640 nm of the mixtures was measured.
DNase activity was determined by a decrease of absorbance at 640 nm of the mixtures, which indicates degradation of DNA in the substrate. Percent residual DNA was determined relative to the absorbance of negative control.
| DNase zymography
Mycoplasma culture supernatants were subjected to SDS-PAGE using polyacrylamide gel containing 100 μg/ml of salmon sperm DNA.
Following electrophoresis, SDS was removed from the gel by washing in 50 mM Tris-HCl (pH 7.4) containing 1% Triton-X100 for an hour.
Subsequently, the gel was incubated in 50 mM Tris-HCl (pH 7.4) for 12 hr at 37°C in the presence or absence of 1 mM MgCl 2 , 1 mM CaCl 2 , 1 mM ZnCl 2 , and 1 mM EDTA. After washing the gel with distilled water, DNA was stained with ethidium bromide, and the nuclease activity was examined under UV light.
4.12 | Screening of transposon mutant of M. pneumoniae deficient in nuclease production
Transposon vector pISM2062 was introduced into M. pneumoniae by electroporation using Gene Pulser (Bio-Rad, Hercules, CA), and the transformants were selected by incubation at 37°C on PPLO agar plates containing 20 μg/ml gentamicin. The gentamicin-resistant bacteria were then inoculated in PPLO broth and cultured to the middle to late log-phase. Culture supernatants were collected by centrifugation, and the nuclease activity was examined by DNase assay as described above.
To determine the transposon-inserted sequence, genomic DNA from a mutant M. pneumoniae deficient for the nuclease was purified, digested by MboI (New England Biolabs, Beverly, MA) and circularized by Ligation high (TOYOBO, Osaka, Japan). DNA sequence of transposon-inserted region was isolated by inverse PCR with following primer set: 5′-CACCTGACGTCGCCTGATACATACATTTCC-3′ and 5′-TTTACGGTTCATTGTGGAAGAACTTTGTGG-3′. The amplified PCR product was cloned into pUC19 using an In-Fusion HD cloning kit (Takara bio, Shiga, Japan), and the transposon-inserted sequence was analyzed by DNA sequencing.
| Quantitative RT-PCR analysis of mpn491 expression
Mice were infected intranasally with 1.0 × 10 7 CFU of M. pneumoniae, and BALFs were collected at 3 and 24 hr after infection. Total RNA was extracted using an ReliaPrep RNA Cell Miniprep System (Promega, Madison, WI) and subjected to reverse transcription using PrimeScript RT reagent Kit (Takara bio). Quantitative RT-PCR was performed on an Opticon 2 (Bio-rad) using an iQ SYBR Green Supermix (Bio-rad) with 4.14 | In vivo analysis of Mpn491 in the evasion of NETs-mediated killing
To induce NETs formation, mice were treated intranasally with 10 μg of LPS from E. coli 055:B5. One day after LPS treatment, mice were infected intranasally with 1.0 × 10 7 CFU of M. pneumoniae, and BALFs were collected at 24 hr after infection. NETs degradation was analyzed by quantification of free DNA in BALFs and was confirmed by the immunofluorescent staining and the microscopic observation as described above. Quantification of free DNA was performed according to the method described previously with some modification (Pilsczek et al., 2010) . The free DNA was stained with 1 μM Sytox green, and the fluorescence was measured by Fluoroskan Ascent (Theremo Fisher Scientific). The concentration of DNA was determined on the basis of standard curve generated using salmon sperm DNA. For the quantification of M. pneumoniae in BALFs, we extracted total RNA from BALFs and performed quantitative RT-PCR using the 16S rRNA as the target to quantify M. pneumoniae. The data were expressed as a fold change compared to the relative amount of 16S rRNA in BALFs obtained from mice infected with the wild-type strain of M. pneumoniae.
| Statistical analysis
For comparisons between two groups, Student's t test was used. In the case that the assumption of homogeneity of variance was rejected by F-test, statistical significance was calculated using Welch's t test. In in vivo study, statistical significance in the difference between experimental groups was determined by Exact Wilcoxon test.
Statistical analyses were performed using JMP Pro software, version 12.2.0 (SAS Institute Inc, Cary, NC). Statistical significance was determined as p < 0.05.
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